# US 2022/0089560 A1 · Compositions of &#916;10-THC and &#916;6a10-THC

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0089560 A1
- Document ID: US20220089560A1
- Status: Published application
- Kind: A1
- Application number: 17/028,824
- Filed: 2020-09-22
- Published: 2022-03-24
- Earliest claimed: 2020-09-22
- Inventors: Alexander William Siegel; Devin Jay Wall; Alek Enrique Valle
- Web page: https://patentgrep.com/patent/US20220089560A1

## CPC

- C07D 311/80: Dibenzopyrans; Hydrogenated dibenzopyrans
- A61K 31/658: {o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol}
- C07C 37/06: by conversion of non-aromatic six-membered rings or of such rings formed in situ into aromatic six-membered rings, e.g. by dehydrogenation
- C07C 37/84: by crystallisation
- C07C 37/86: by treatment giving rise to a chemical modification (chemisorption C07C37/82)
- C07C 39/19: containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
- C07C 39/21: with at least one hydroxy group on a non-condensed ring
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

Compositions of Δ10-THC and Δ6a10a-THC are prepared and described. The conversions do not affect existing CBD or CBG in the extract. Various adjustments can be made to the reactions resulting in increased or decreased product and by-product. Various formulations with medical uses are disclosed.

## Claims

### Claim 1

The conversion of psychoactive THC to one or more non-psychoactive cannabinoids.

### Claim 2 (depends on 1)

The method of claim 1 performed in the presence of at least one other cannabinoid besides said THC, without degrading said other existing cannabinoid.

### Claim 3 (depends on 1)

The method of claim 1 performed in the presence of CBD, cannabigerol, or Δ8-THC, without degrading more than 75% of said CBD, cannabigerol, or Δ8-THC.

### Claim 4

A composition comprising Δ10-THC and at least one other cannabinoid.

### Claim 5 (depends on 4)

The composition of claim 4; wherein said other cannabinoid is Δ6a10a-THC.

### Claim 6 (depends on 4)

The composition of claim 4; wherein said other cannabinoid is Δ8-THC.

### Claim 7 (depends on 4)

The composition of claim 4; wherein said other cannabinoid is Δ9-THC.

### Claim 8 (depends on 4)

The composition of claim 4; wherein said other cannabinoid is cannabinol.

### Claim 9 (depends on 4)

The composition of claim 4; wherein said other cannabinoid is cannabidiol.

### Claim 10 (depends on 4)

The composition of claim 4; wherein said other cannabinoid is cannabigerol.

### Claim 11 (depends on 4)

The composition of claim 4; wherein said other cannabinoid is cannabichromene.

### Claim 12 (depends on 5)

The composition of claim 5; wherein said other cannabinoid is cannabinol.

### Claim 13 (depends on 5)

The composition of claim 5; wherein said other cannabinoid is Δ8-THC.

### Claim 14 (depends on 8)

The composition of claim 8; wherein said other cannabinoid is Δ8-THC.

### Claim 15 (depends on 12)

The composition of claim 12; wherein said other cannabinoid is Δ8-THC.

### Claim 16

A composition comprising Δ6a10a-THC and at least one other cannabinoid.

### Claim 17 (depends on 16)

The composition of claim 16; wherein said other cannabinoid is Δ8-THC.

### Claim 18 (depends on 16)

The composition of claim 16; wherein said other cannabinoid is Δ9-THC.

### Claim 19 (depends on 16)

The composition of claim 16; wherein said other cannabinoid is cannabinol.

### Claim 20 (depends on 16)

The composition of claim 16; wherein said other cannabinoid is cannabidiol.

### Claim 21 (depends on 16)

The composition of claim 16; wherein said other cannabinoid is cannabigerol.

### Claim 22 (depends on 16)

The composition of claim 16; wherein said other cannabinoid is cannabichromene.

### Claim 23 (depends on 2)

The conversion of claim 2; wherein said cannabinoid is an acidic cannabinoid.

### Claim 24 (depends on 4)

The composition of claim 4; wherein said cannabinoid is an acidic cannabinoid.

### Claim 25 (depends on 16)

The composition of claim 16; wherein said cannabinoid is an acidic cannabinoid.

### Claim 26 (depends on 9)

The composition of claim 9; further comprising CBN.
